뒤로
TYK Medicines, Inc(02410.HK) 가격
02410.HK 주가 차트
TYK MEDICINES-B (02410.HK)
TYK Medicines, Inc
HK$13.56
-2.72%
$-0.37
장 종료: Jan 16, 16:00:00 HKT
아직 데이터 없음Follow-Up Questions
TYK Medicines, Inc의 주요 재무제표는 무엇인가요?
02410.HK의 주요 재무 비율은 무엇인가요?
TYK Medicines, Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
TYK Medicines, Inc은 수익성이 있나요?
TYK Medicines, Inc에 부채가 있나요?
TYK Medicines, Inc의 발행 주식은 몇 주인가요?
주요 통계
이전 종가
$13.72
시가
$13.94
일일 범위
$13.4 - $13.94
52주 범위
$12.1 - $46.1
거래량
2.0M
평균 거래량
3.3M
EPS(TTM)
-0.84
배당수익률
--
시가총액
$5.0B
TYK MEDICINES-B란 무엇인가요?
TYK Medicines, Inc. operates as a clinical-stage biopharmaceutical company. The company is headquartered in Shanghai, Shanghai and currently employs 163 full-time employees. The company went IPO on 2024-08-20. The firm is primarily focused on small molecule drug development, and its main products include TY-9591, TY-302 and TY-2136. TY-9591 is a third-generation EGFR-TKI with antitumor effects on EGFR mutations. TY-302 is a potent, selective oral CDK4/6 inhibitor developed for the treatment of advanced solid tumors, including breast cancer and prostate cancer. TY-2136b is an internally developed, oral ROS1/NTRK inhibitor for the treatment of solid tumors.